HF
ONCT

HRT Financial’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

HRT Financial’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,678
Closed -$37K – 3708
2022
Q2 		$37K Buy
+1,678
New +$37.4K ﹤0.01% 2541
2021
Q2 		– Sell
-1,437
Closed -$239K – 3706
2021
Q1 		$239K Buy
+1,437
New +$190K ﹤0.01% 2224

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

HRT Financial's ONCT Position: Q3 2022 in Review

HRT Financial sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2022, closing a stake of 1,678 shares — an estimated $37K sold.

HRT Financial first reported a position in ONCT in Q1 2021 and held it in 2 quarters. The position peaked at $239K in Q1 2021. 61 funds tracked by Wall St. Rank hold ONCT as of Q3 2022.

  • HRT Financial reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 1,678 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $37K.
  • HRT Financial first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • HRT Financial's Oncternal Therapeutics, Inc. Common Stock position peaked at $239K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.